Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Consistent retention and disposition of managed content and associated metadata
Tone enhancement bracket
Decision management system and method
Semiconductor chip, stack module, and memory card
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT.sub.6 receptor
Data paths using a first signal to capture data and a second signal to output data and methods for providing data
Case for electronic device
  Randomly Featured Patents
Massage tool
Power cylinder balancer unit
Flow control for multi-hop networks
Zoom lens system and camera including the same
Process for providing a vector image with removed hidden lines
Container seal prover
Smart antenna for RF receivers
Apparatus and method for driving plasma display panel
Automated parking system and subassemblies therefor
Apparatus for passive removal of subsurface contaminants and mass flow measurement